Parkinsons Disease Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Parkinsons Disease

Parkinson's disease, a movement disorder, is a progressive neurological disorder, the condition progresses over time. In Parkinson's disease, the cells which are responsible to secrete dopamine begin to die. Dopamine is responsible for the smooth functioning of the muscle of the body. Dopamine is secreted by the cells of the substantia nigra, a part of the brain.

Parkinson's disease symptoms including the change in voice, slurry voice, tremor, slow movements, anosmia, balancing problem, stiffness of arms, legs and trunks, facial expression start to change, and loss of sense of smell. These symptoms are due to a decrease in levels of dopamine leading to abnormal brain activity.

The cause which leads to low levels of dopamine is not yet clear. But there are many factors which lead to Parkinson's disease, maybe genetic factors and environmental causes. As there is no specific test to diagnose Parkinson's disease, a dopamine transporter test scan can be used.

Sub-tracks:

Signs and symptoms of Parkinson's disease
Secondary Parkinsonism
Parkinsonian gait
Brain cell death
Parkinsonism
Bradykinesia
Parkinson’s care, rehabilitation, and treatments

Market Analysis: In the United States, it is the second most common neurodegenerative disorder.The global Parkinson's disease treatment market is predicted to grow at a CAGR of 6.1 percent from USD 4.24 billion in 2017 to USD 5.69 billion in 2022. The market is being driven by the growing ageing population and government financing for Parkinson's disease research. The Parkinson's disease (PD) market is predicted to develop significantly in the next seven years, with a 12.6 percent compound annual growth rate starting in 2019. (CAGR). Parkinson's disease is expected to affect 1.2 million people in the United States by 2030, according to the National Institute of Health.

Tracks